161 related articles for article (PubMed ID: 15340130)
1. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
Kirian MA; Higginson RT; Fulco PP
Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
[TBL] [Abstract][Full Text] [Related]
3. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
4. Adverse events experienced by three children taking tenofovir and didanosine in combination.
Hawkins S; Ball C
HIV Med; 2007 Sep; 8(6):411. PubMed ID: 17661851
[No Abstract] [Full Text] [Related]
5. Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.
Ripamonti D; Maggiolo F; Suter F
AIDS; 2007 May; 21(8):1059-60. PubMed ID: 17457107
[No Abstract] [Full Text] [Related]
6. Effect of tenofovir on didanosine absorption in patients with HIV.
Pecora Fulco P; Kirian MA
Ann Pharmacother; 2003 Sep; 37(9):1325-8. PubMed ID: 12921517
[TBL] [Abstract][Full Text] [Related]
7. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine.
Murphy MD; O'Hearn M; Chou S
Clin Infect Dis; 2003 Apr; 36(8):1082-5. PubMed ID: 12684925
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir and didanosine: a dangerous liaison.
Waters L; Maitland D; Moyle GJ
AIDS Read; 2005 Aug; 15(8):403-6, 413. PubMed ID: 16110555
[No Abstract] [Full Text] [Related]
9. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
[TBL] [Abstract][Full Text] [Related]
10. Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen.
Lowe SH; van Leeuwen E; Droste JA; van der Veen F; Reiss P; Lange JM; Burger DM; Repping S; Prins JM
Ther Drug Monit; 2007 Oct; 29(5):566-70. PubMed ID: 17898645
[TBL] [Abstract][Full Text] [Related]
11. Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
Barreiro P; Soriano V
J Antimicrob Chemother; 2006 May; 57(5):806-9. PubMed ID: 16531427
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
[TBL] [Abstract][Full Text] [Related]
13. Acute renal failure after initiation of tenofovir disoproxil fumarate.
Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
[TBL] [Abstract][Full Text] [Related]
15. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
17. CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
Kakuda TN; Anderson PL; Becker SL
AIDS; 2004 Dec; 18(18):2442-4. PubMed ID: 15622326
[No Abstract] [Full Text] [Related]
18. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Cotte L; Bénet T; Billioud C; Miailhes P; Scoazec JY; Ferry T; Brochier C; Boibieux A; Vanhems P; Chevallier M; Zoulim F
J Hepatol; 2011 Mar; 54(3):489-96. PubMed ID: 21056493
[TBL] [Abstract][Full Text] [Related]
19. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
Atta MG; Fine DM
AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
[No Abstract] [Full Text] [Related]
20. Hypokalemia in HIV patients on tenofovir.
Cirino CM; Kan VL
AIDS; 2006 Aug; 20(12):1671-3. PubMed ID: 16868451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
